National Cancer Centre Singapore (NCCS) shared on LinkedIn:
“NCCS signed an MoU today to formalise our partnership with National Cancer Centre Hospital Japan, one of the world’s leading cancer centres. NCCS is a part of the ATLAS Project (Asian Clinical Trials Network for Cancers), a multinational initiative led by NCCH Japan to establish a clinical trial network across Asia.
This MoU strengthens and expands our collaboration across research, education, and clinical trials. With strong regional collaboration, we will improve cancer outcomes and create a future where cancer is no longer a life-threatening diagnosis for patients across Asia.”
Other articles about National Cancer Centre Singapore on OncoDaily.
